Immunolocalization of stromelysin, tumor necrosis factor (TNF) α, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor β

American Journal of Veterinary Research

Volumn 57, Issue 10, 1996, Pages 1488-1496

  Comer, Joan S ^a   Kincaid, Steven A ^a   Baird, Aubrey N ^a   Kammermann, John R ^a   Hanson Jr , Reid R ^a   Ogawa, Yasushi ^b  

^a AUBURN UNIVERSITY   (United States)

^b Celtrix Pharmaceutical Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DOG; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTRAARTICULAR DRUG ADMINISTRATION; MALE; NONHUMAN;

ANIMALS; ANTIBODIES; ATROPHY; CARTILAGE, ARTICULAR; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HINDLIMB; HYALURONIC ACID; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 3; RECEPTORS, TUMOR NECROSIS FACTOR; STIFLE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BIVALVIA; CANIS FAMILIARIS;

EID: 0029969824     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Buckwalter J, Rosenberg L, Coutts R, et al. Articular cartilage. In: Woo SL, Buckwalter JD, eds. Injury and repair of the musculoskeletal soft tissues. Park Ridge, Ill: American Academy of Orthopedic Surgeons, 1988;465-481.
2. Mow VC, Setton LA, Ratcliffe A, et al. Structure - function relationships of articular cartilage and the effects of joint instability and trauma on cartilage function. In: Brandt KD, ed. Osteoarthritis. Indianapolis: Indiana University School of Medicine, 1990;22-42.
3. Poole AR. Enzymatic degradation: cartilage destruction. In: Brandt KD, ed. Osteoarthritis. Indianapolis: Indiana University School of Medicine, 1990;63-72.
4. Tartagalia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;13:151-153.
5. Vilcek J, Lee TH. Tumor necrosis factor new insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991; 266:7313-7316.
6. Cope AP, Aderka D, Doherty M, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-1169.
7. Vilcek J, Palombella VJ. TNF as a growth factor. Immunol Ser 1990;56:269-287.
8. Palmoski M, Perricone E, Brandt KD. Development and reversal of a proteoglycan aggregation defect in normal canine knee cartilage after immobilization. Arthritis Rheum 1979;22:508-517.
9. Palmoski MJ, Colyer RA, Brandt KD. Joint motion in the absence of normal loading does not maintain normal articular cartilage. Arthritis Rheum 1980;23:325-334.
10. Helminen HJ, Kiviranta I, Saamanen A, et al. Effect of motion and load on articular cartilage in animal models. In: Kuettner KE, Schleyerbach R, Peyron JG, et al, eds. Articular cartilage and osteoarthritis. New York: Raven Press Ltd, 1992;501-510.
11. Sporn MB, Roberts AB, Wakefield LM, et al. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987;105:1039-1045.
12. Villiger PM, Lotz M. Differential expression of TGF-β isoforms by human articular chondrocytes in response to growth factors. J Cell Physiol 1992;151:318-325.
13. O'Keefe RJ, Puzas JE, Brand JS, et al. Effect of transforming growth factor-β on DNA synthesis by growth plate chondrocytes: modulation by factors present in serum. Tissue Int 1988;43:352-358.
14. Morales TI, Roberts AB. Transforming growth factor β regulates the metabolism of proteoglycans in bovine cartilage organ cultures. J Biol Chem 1988;263:12828-12831.
15. Morales TI. Transforming growth factor-β1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 1991;286:99-106.
16. Morales TI, Joyce ME, Sobel ME, et al. Transforming growth factor-β in calf articular cartilage organ cultures: synthesis and distribution. Arch Biochem Biophys 1991;288:397-405.
17. Redini F, Daireaux M, Mauviel A, et al. Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to transforming growth factor-beta (TGF-β). Biochim Biophys Acta 1991;1093:196-206.
18. van der Kraan P, Vitters EL, van den Berg WB. Inhibition of proteoglycan synthesis by transforming growth factor β in anatomically intact articular cartilage of murine patellae. Ann Rheum Dis 1992;51:643-647.
19. Howard RD, McIlwraith CW. Sodium hyaluronate in the treatment of equine joint disease. Compend Contin Educ Pract Vet 1993;15:473-479.
20. Antonas KN, Fraser JRE, Muirden KD. Distribution of biologically labeled radioactive hyaluronic acid injected into joints. Ann Rheum Dis 1973;32:103-111.
21. Hilbert BJ, Rowley G, Antonas KN, et al. Changes in the synovia after the intra-articular injection of sodium hyaluronate into normal horse joints and after arthrotomy and experimental cartilage damage. Aust Vet J 1985;62:182-183.
22. Brown TJ, Laurent UBG, Fraser JRE. Turnover of hyaluronan in synovial joints: elimination of labeled hyaluronan from the knee joint of the rabbit. Exp Physiol 1991;76:125-134.
23. Shimazu A, Jikko A, Iwamoto M, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993;36:247-253.
24. Keller WG, Aron DN, Rowland GN, et al. The effect of trans-stifle external skeletal fixation and hyaluronic acid therapy on articular cartilage in the dog. Vet Surg 1994;23:119-128.
25. Larsen NE, Lombard KM, Parent EG, et al. Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 1992;10:23-32.
26. Mejersjo C, Kopp S. Effect of corticosteroid and sodium hyaluronate on induced joint lesions in the guinea-pig knee. Int J Oral Moxillofac Surg 1987;16:194-201.
27. Schiavinato A, Lini E, Guidolin D, et al. Intraarticular sodium hyaluronate injections in the pond-nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop 1989;241:286-299.
28. Abatangelo G, Botti P, Del Bue M, et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. 1. Biochemical results. Clin Orthop 1989; 241:278-285.
29. Rydell N, Balazs EA. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop 1971;80:25-32.
30. Pelletier JP, Faure MP, DiBattista JA, et al. Coordinate synthesis of stromelysin, interleukin-1 and oncogene proteins in experimental osteoarthritis. Am J Pathol 1993;142:95-105.
31. Wigren A, Wik O, Falk J. Repeated intraarticular implantation of hyaluronic acid. Ups J Med Sci Suppl 1975;17:2-20.
32. Wahl RC, Dunlap RP, Morgan BA. Biochemistry and inhibition of collagenase and stromelysin. In: Bristol JA, Johns WF, eds. Annual reports in medicinal chemistry-25. New York: Academic Press Inc, 1989;177-184.
33. Brinckerhoff CE. Joint destruction in arthritis: metalloproteinases in the spotlight. Arthritis Rheum 1991;34:1073-1075.
34. Okada Y, Shinmei M, Tanaka O, et al. Location of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-690.
35. Shinmei M, Masuda K, Kikuchi T, et al. Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol 1991;18(Suppl 27):89-91.
36. Nguyen Q, Mort JS, Roughley PJ. Preferential mRNA expression of prostromelysin relative to precollagenous and in situ localization in human articular cartilage. J Clin Invest 1992;89:1189-1197.
37. Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-685.
38. Peyron JG. A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthritis Cart 1993;1:85-87.
39. Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol 1994;12:75-82.
40. Anastassiades T, Robertson W. Modulation of mitogen-dependent lymphocyte stimulation by hyaluronic acid. J Rheumatol 1984;11:729-734.
41. Brandt KD. Modification of chemotaxis by synovial fluid hyaluronate. Arthritis Rheum 1970;13:308-309.
42. Balazs EA, Darzynkiewicz Z. The effect of hyaluronic acid on fibroblasts, mononuclear phagocytes, and lymphocytes. In: Biology of the fibroblast. New York: Academic Press Inc, 1973;237-252.
43. Gingerich DA. Effect of exogenous hyaluronic acid on joint function in experimentally induced equine osteoarthritis: dosage titration studies. Res Vet Sci 1981;30:192-197.
44. Auer JA, Fackelman GE, Gingerich DA, et al. Effect of hyaluronic acid in naturally occurring and experimentally induced osteoarthritis. Am J Vet Res 1980;41:568-574.
45. Asheim A, Lindblad G. Intra-articular treatment of arthritis in race-horses with sodium hyaluronate. Acta Vet Scand 1976;17: 379-394.
46. Olsen EB, Trier K, Jørgensen B, et al. The effect of hyaluronic acid on cartilage in the immobilized rabbit knee. Acta Orthop Scand 1991;62:323-326.
47. Yasui T, Akatsuka M, Tobetto K, et al. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 1992;13:343-348.
48. Pickvance EA, Oegema TR Jr, Thompson RC Jr. Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading. J Orthop Res 1993;11:313-323.
49. Palmoski MJ, Brandt KD. Immobilization of the knee prevents osteoarthritis after anterior cruciate ligament transection. Arthritis Rheum 1982;25:1201-1208.
50. Pelletier P, Malemud CJ. Proteoglycans from experimental osteoarthritic cartilage: degradation by neutral metalloproteinases. J Rheumatol 1987;14(Suppl 14):113-115.
51. Chang N-S, Intrieri C, Mattison J, et al. Synthetic polysulfated hyaluronic acid is a potent inhibitor for tumor necrosis factor production. J Leukocyte Biol 1994;55:778-784.
52. Bollet AJ, Bonner WM Jr, Nance JL. The presence of hyaluronidase in various mammalian tissues. J Biol Chem 1963;238: 3522-3527.
53. Bollet AJ, Nance JL. Biochemical findings in normal and osteoarthritic articular cartilage. II. Chondroitin sulfate concentration and chain length, water, and ash content. J Clin Invest 1966;45: 1170-1177.
54. Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press Ltd, 1992;541-588.
55. Allen JB, Manthey CL, Hand AR, et al. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J Exp Med 1990;171:231-247.
56. Shinmei M, Masuda K, Kikuchi T, et al. Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction. Semin Arthritis Rheum 1989;18(Suppl 1):27-32.
57. Beutler B, Cerami A. The biology of cachetin/TNF-α primary mediator of the host response. Annu Rev Immunol 1989;7:625-655.
58. Elford PR, Graeber M, Hiroshi O, et al. Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intraarticular injection of transforming growth factor β-2 in the rabbit. Cytofeine 1992;4:232-238.
59. Venn G, Lauder RM, Hardingham TE. Effects of catabolic and anabolic cytokines on proteoglycan biosynthesis in young, old and osteoarthritic canine cartilage. Biochem Soc Trans 1990;18:973-974.
60. Hardington TE, Bayliss MT, Rayan V, et al. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Br J Rheumotol 1992;31(Suppl 1):1-6.
61. Vivien D, Redini F, Galéra P, et al. Rabbit articular chondrocytes (rac) express distinct transforming growth factor-β receptor phenotypes as a function of cell cycle phases. Exp Cell Res 1993; 205:165-170.
62. Wahl SM, Hunt D, Wakefield LM, et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 1987;84:5788-5792.
63. Brandes ME, Allen JB, Ogawa Y, et al. Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991;87:1108-1113.
64. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type B: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986;83:4167-4171.
65. Muller G, Behrens J, Nussbaumer U, et al. Inhibitory action of transforming growth factor β on endothelial cells. Proc Natl Acad Sci U S A 1987;84:5600-5604.
66. Heimark RL, Twardzik DR, Schwartz SM. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986;233:1078-1080.
67. Knudson C, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB J 1993;7:1233-1241.